FAT1 and squamous cell carcinoma: Recent advancements in next‐generation sequencing (NGS) have revealed that mutations in the FAT1 gene and the subsequent activation of the Wnt/β‐catenin signaling pathway may contribute to chemoresistance in well‐differentiated squamous cell carcinoma compared to poorly differentiated tumors.28